Braveheart Bio (BRVE) vs First Tracks Biotherapeutics (TRAX)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
First Tracks Biotherapeutics is the larger company by market cap ($1.75 billion vs $1.67 billion), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | BRVE | TRAX |
|---|---|---|
| Share price | $20.39 | $41.64 |
| Market cap | $1.67B | $1.75B |
| 1-day change | +5.81% | -6.34% |
| EPS (TTM) | $-6.59 | $-4.71 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $32.00 | $54.78 |
| 52-week low | $16.70 | $14.72 |
| Distance from 52-week high | -36.28% | -23.99% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +123.15% | +80.52% |
| Average volume | 491.27K | 826.70K |
| Shares outstanding | 82.07M | 42.02M |
| Employees | 49 | 104 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Braveheart Bio
BRVE stock →Braveheart Bio, Inc. a clinical-stage biopharmaceutical company focused on developing therapies for patients with hypertrophic cardiomyopathy (HCM) and other serious cardiovascular diseases.
Health Care · Biotechnology: Pharmaceutical Preparations · 49 employees
About First Tracks Biotherapeutics
TRAX stock →First Tracks Biotherapeutics, Inc. operates a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases in United States.
Health Care · Biotechnology: Pharmaceutical Preparations · 104 employees
BRVE vs TRAX FAQ
Which is bigger, Braveheart Bio or First Tracks Biotherapeutics?
First Tracks Biotherapeutics (TRAX) is larger, with a market capitalization of $1.75B compared with $1.67B for Braveheart Bio (BRVE).
Are Braveheart Bio and First Tracks Biotherapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.